Bladder Cancer

Xpert bladder cancer monitor in surveillance of bladder cancer: Systematic review and meta-analysis. September 21, 2021

A qPCR-based method for molecular subtype classification of urinary bladder cancer - stromal gene expressions show higher prognostic values than intrinsic tumor genes. September 21, 2021

Computed-tomography based scoring system predicts outcome for clinical lymph node-positive patients undergoing radical cystectomy. September 20, 2021

Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort Study. September 20, 2021

Prediction of neo-adjuvant chemotherapy response in bladder cancer: the impact of clinical parameters and routine biomarkers. September 17, 2021

Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer. September 17, 2021

PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers. September 16, 2021

Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies. September 16, 2021

TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer. September 16, 2021

Does Prior Pelvic Radiation Therapy Impact on Outcomes of Patients with Bladder Cancer? - Expert Commentary September 15, 2021

Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey. September 15, 2021

Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study. September 15, 2021

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). September 15, 2021

Survival of bladder or renal cancer in patients with CHEK2 mutations. September 14, 2021

Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer. September 14, 2021

Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin. September 13, 2021

Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis. September 13, 2021

Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma. September 13, 2021

Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop. September 13, 2021

Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer. September 10, 2021

Page 1 of 405